Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Audit and Feedback for General Practitioners in the Intego Network

8 de marzo de 2022 actualizado por: Tine De Burghraeve

Audit and feedback is an extensively investigated quality intervention, which according to the last Cochrane review leads to small but potentially important improvements in professional practice. There is some evidence that feedback can improve EHR registration but the effect and important features of feedback are still the subject of debate. Previous work has identified some testable and theory-informed hypotheses for designing an audit and feedback intervention and suggestions to improve the effectiveness of the intervention are available in literature. There are several criteria feedback could meet to have an impact on the registration level of GP's in the EHR. The researchers now want to evaluate if the effort to make an extended feedback intervention has an effect on the registration behavior of the GP.

The research question is: Does an audit and extended feedback intervention improves the quality of registration in the EHR of the general physician compared to basic feedback?

Descripción general del estudio

Descripción detallada

Intego is a Belgian general practice-based morbidity registration network at the Department of General Practice of the University of Leuven. Intego collects data on health parameters, incidence and prevalence rates, laboratory results, and prescribed drugs for all relevant subgroups. It is unique in Belgium. These data are used as a basis for teaching, quality improvement interventions, and research, as well as for policy making by both physicians' organizations and governmental bodies. The health ministry of the Flemish government mainly funds the network. Ad hoc research projects serve as an additional funding source.

Up until 2017, 97 general practitioners (GP's) of 55 practices evenly spread throughout Flanders, Belgium, collaborated in Intego. GP's applied for inclusion in the registry. Before acceptance of their data, registration performance was audited using algorithms to compare their results with those of all other applicants. Only data of practices with optimal registration performance that met our three quality requirements were included in the database. First, the average number of new diagnoses per patient per year should be higher than one. Second, diagnoses have to be entered in the practice software using keywords. The Intego GP's prospectively and routinely registered all new diagnoses and new drug prescriptions, as well as laboratory test results and patient information. The registration made use of computer-generated keywords internally linked to codes [International Classification of Primary Care (ICPC-2) and International Statistical Classification of Diseases and Related Health Problems 10th Revision (ICD-10) for diagnoses and WHO's Anatomical Therapeutic Chemical (ATC) classification system for drugs]. The percentage of diagnoses recorded without using keywords should be less than 5%. Finally, these parameters must remain stable for at least three years.

In 2017, Intego made a transition in data infrastructure and size of the network.

Further information technology development for the electronic health record (EHR) 'Medidoc' was terminated, and all its users were urged by the vendor to migrate to a new EHR, called CareConnect (Corilus), a cloud-based EHR. This transition marked the moment to redesign the data collection for this registry, which had not changed since its start. To comply with the new General Data Protection Regulation legislation, the Healthdata.be platform was identified as a partner for this task.

Moreover, the number of practices was increased and now counts 107 practices (410 GPs). However, new GP practices might not meet the quality requirements for good registration yet.

The data completeness of the EHR is thus an important factor to consider when reusing data stored in the EHR. Other pitfalls and sources of bias when using EHR data have also been identified. In order to improve registration, we want to implement extended electronically delivered feedback and evaluate its effects on correctly registering the diagnosis of chronic diseases and lifestyle habits in the EHR.

Audit and feedback is an extensively investigated quality intervention, which according to the last Cochrane review leads to small but potentially important improvements in professional practice. There is some evidence that feedback can improve EHR registration but the effect and important features of feedback are still the subject of debate. Previous work has identified some testable and theory-informed hypotheses for designing an audit and feedback intervention and suggestions to improve the effectiveness of the intervention are available in literature. There are several criteria feedback could meet to have an impact on the registration level of GP's in the EHR. We now want to evaluate if the effort to make an extended feedback intervention has an effect on the registration behavior of the GP.

The research question is: Does an audit and extended feedback intervention improves the quality of registration in the EHR of the general physician compared to basic feedback?

Tipo de estudio

Intervencionista

Fase

  • No aplica

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Niño
  • Adulto
  • Adulto Mayor

Acepta Voluntarios Saludables

Sí

Géneros elegibles para el estudio

Todos

Descripción

inclusion criteria:

  • This trial has the general practices as the level of allocation.
  • All GPs in the Intego network will be asked to participate in this trial.
  • For GPs working in a group, the whole group will be asked to collaborate.

Exclusion criteria:

- If not all GPs in a group practice want to collaborate in the intervention study, the whole GP practice will not be included in this study.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Otro
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Único

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Extended audit and feedback

The intervention consists of an extended electronically delivered feedback with multiple components which will be delivered 4 times electronically into general practices over 12 months.

This extended feedback report consists of:

  • Benchmarking of the results of the audit versus peers, versus guidelines and versus disease specific laboratory results.
  • A low cognitive load of the feedback where the results will be presented with the help of graphs.
  • Action plans to improve the quality of registration
  • A push system to minimize the effort the GP must make to consult the feedback.

The intervention consists of an extended electronically delivered feedback with multiple components which will be delivered 4 times electronically into general practices over 12 months.

This extended feedback report consists of:

  • Benchmarking of the results of the audit versus peers, versus guidelines and versus disease specific laboratory results.
  • A low cognitive load of the feedback where the results will be presented with the help of graphs.
  • Action plans to improve the quality of registration
  • A push system to minimize the effort the GP must make to consult the feedback.
Comparador activo: Basic feedback
In the past, all GPs received basic feedback on the level of registration in the EHR and this form of feedback will still be provided in the control group. By providing all GPs a basic level of feedback, we do not change the former protocol and all GPs will receive the opportunity to improve their registration performance. Only the way of receiving feedback is more straightforward, the GP needs to login to HealthStat.be.

The intervention consists of an extended electronically delivered feedback with multiple components which will be delivered 4 times electronically into general practices over 12 months.

This extended feedback report consists of:

  • Benchmarking of the results of the audit versus peers, versus guidelines and versus disease specific laboratory results.
  • A low cognitive load of the feedback where the results will be presented with the help of graphs.
  • Action plans to improve the quality of registration
  • A push system to minimize the effort the GP must make to consult the feedback.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
percentage registered diagnoses of DM 2 in the EHR
Periodo de tiempo: 12 months
Registered diagnosis of type II diabetes in GPs electronic health record
12 months

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Percentage registered lifestyle factors
Periodo de tiempo: 12 months
Registration of lifestyle habits such as alcohol and tobacco use
12 months
percentage registered diagnoses of heart failure
Periodo de tiempo: 12 months
Registered diagnosis of heart failure in GPs electronic health record
12 months

Otras medidas de resultado

Medida de resultado
Medida Descripción
Periodo de tiempo
CKD follow-up quality indicator
Periodo de tiempo: 12 months
Percentage of patients with CKD in whom the GFR, albuminuria and total protein is determined at least once a year
12 months
CKD vaccination quality indicator
Periodo de tiempo: 12 months
Percentage of patients with CKD who received a pneumococcal vaccination
12 months
Diabetes treatment quality indicator
Periodo de tiempo: 12 months
Percentage of patients with diabetes and CKD who no longer receive metformin
12 months
Diabetes follow-up quality indicator
Periodo de tiempo: 12 months
Percentage of patients with diabetes whose HbA1c level is measured at least once every 6 months
12 months

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Investigadores

  • Investigador principal: Tine De Burghgraeve, PhD, KU Leuven

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

30 de enero de 2022

Finalización primaria (Actual)

28 de febrero de 2022

Finalización del estudio (Actual)

28 de febrero de 2022

Fechas de registro del estudio

Enviado por primera vez

11 de mayo de 2020

Primero enviado que cumplió con los criterios de control de calidad

11 de mayo de 2020

Publicado por primera vez (Actual)

14 de mayo de 2020

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

22 de marzo de 2022

Última actualización enviada que cumplió con los criterios de control de calidad

8 de marzo de 2022

Última verificación

1 de marzo de 2022

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • S62753

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir